DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors

Published:2019-03 Issue:3 Volume:35 Page:519-533.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Pillay Nisha,Tighe Anthony,Nelson Louisa,Littler Samantha,Coulson-Gilmer Camilla,Bah Nourdine,Golder Anya,Bakker Bjorn,Spierings Diana C.J.,James Dominic I.,Smith Kate M.,Jordan Allan M.,Morgan Robert D.,Ogilvie Donald J.,Foijer Floris,Jackson Dean A.,Taylor Stephen S.

Funder

Cancer Research UK

Wellcome Trust

Medical Research Council

The Netherlands Organisation for Scientific Research, The Netherlands

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference70 articles.

1. Replication in hydroxyurea: it's a matter of time;Alvino;Mol. Cell. Biol.,2007

2. Synthetic lethal therapies for cancer: what's next after PARP inhibitors?;Ashworth;Nat. Rev. Clin. Oncol.,2018

3. Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity;Bajrami;Cancer Res.,2014

4. Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies;Bakker;Genome Biol.,2016

5. The recognition and removal of cellular poly(ADP-ribose) signals;Barkauskaite;FEBS J.,2013

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer;Frontiers in Oncology;2024-07-29

2. Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation;NAR Cancer;2024-07-09

3. CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer;Cell Death Discovery;2024-06-11

4. Small-Molecule Inhibition of CBX4/7 Hypersensitises Homologous Recombination-Impaired Cancer to Radiation by Compromising CtIP-Mediated DNA End Resection;Cancers;2024-06-06

5. Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients;Journal of Experimental & Clinical Cancer Research;2024-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3